Sascha Hatahet

Dr. Sascha Hatahet

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2025 in Heart Rhythm O2
Verified
Journal Article
Open access
RTRoland Richard Tilz
Roland Richard Tilz
JWJan-Per Wenzel
Jan-Per Wenzel
CECharlotte Eitel
Charlotte Eitel
SPSorin Popescu
Sorin Popescu
JNJulius Nikorowitsch
Julius Nikorowitsch
SHSascha Hatahet
Sascha Hatahet
Pulsed field ablation (PFA) is a novel technique for pulmonary vein isolation (PVI) in atrial fibrillation, offering myocardial selectivity and a favorable safety profile. The balloon-in-basket (BiB)-PFA system enables circumferential PVI with optimized tissue contact. PFA is typically performed under deep sedation or general anesthesia, increasing procedural risk and logistical burden. This study evaluated the safety, feasibility, and patient experience of BiB-PVI under conscious sedation, keeping patients awake and avoiding routine use of propofol. Consecutive patients undergoing de novo PVI were prospectively enrolled. Conscious sedation included fentanyl, midazolam, metamizole, and lidocaine; propofol was used for direct-current cardioversion only. Patient experience was assessed via structured questionnaires at 3 time points: during ablation and 1 hour and 1 day after the procedure. Pain, dyspnea, and anxiety were rated on numeric rating scales (0–10); satisfaction and recommendation were rated on visual analog scales (0%–100%). 14 patients (86% male; age 70.6 ± 9.8 years; BMI 27.7 ± 3.7 kg/m2) were included. Procedure duration was 54.5 minutes (38.3, 60.8); LA dwell time was 23 minutes (19.5, 34.8). 2.5 PFA applications (2.0, 4.0) were delivered per vein (left superior pulmonary vein 2.5; left inferior pulmonary vein 2.5; right inferior pulmonary vein 2.5; right superior pulmonary vein 2.5). Additional ablation strategies were performed owing to the interventionist’s preference. No escalation to deep sedation was required. Pain was 6.5 (4.3, 8.0), decreasing to 2.0 after ablation and on day 1 (P = .002/.001). Dyspnea and anxiety remained low. Satisfaction reached 95% (90, 100) and recommendation 100% (90, 100), remaining high throughout follow-up. PFA using the BiB-PFA system under conscious sedation is safe, feasible, and well tolerated, enabling streamlined workflows with high patient satisfaction.

8 December 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
JWJan‐Per Wenzel
Jan‐Per Wenzel
SHSascha Hatahet
Sascha Hatahet
CECharlotte Eitel
Charlotte Eitel
RARaed Abdessadok
Raed Abdessadok
SPSorin Popescu
Sorin Popescu
RTRoland Richard Tilz
Roland Richard Tilz
Background: Cryoballoon ablation (CB) is a well‐established thermal technique for pulmonary vein isolation (PVI), while balloon‐in‐basket pulsed field ablation (BiB‐PFA) represents a novel non‐thermal alternative. Both single‐shot systems may trigger systemic inflammation and myocardial injury, yet direct comparisons are lacking. This study aimed to compare inflammatory and myocardial biomarker responses following first‐time PVI using CB or BiB‐PFA. Methods: In this prospective, single‐center study, 100 patients undergoing PVI for symptomatic paroxysmal or persistent atrial fibrillation (AF) were enrolled (CB: n = 50; BiB‐PFA: n = 50). Venous blood samples were collected before and on the morning after ablation to assess leukocytes, C‐reactive protein (CRP), platelets, troponin T, creatine kinase (CK), myoglobin, creatinine, and estimated glomerular filtration rate. Baseline characteristics, procedural data, and acute success were analyzed. Results: Patients in the CB group were older (74 vs. 65 years; p = 0.01) and had higher CHA₂DS₂‐VAcore (3.0 vs. 2.0; p = 0.009). Acute PVI was achieved in all cases CB was associated with greater increases in leukocytes (Δ2.5 vs. 1.1 × 10⁹/L; p = 0.05) and CRP (Δ5.8 vs. 3.4 mg/L; p = 0.02), whereas BiB‐PFA showed higher rises in CK (Δ217 vs. 103 U/L; p = 0.01) and troponin T (Δ1129 vs. 614.5 ng/L; p = 0.01). No significant correlation was found between energy delivery and biomarker changes. Conclusion: CB and BiB‐PFA elicit distinct systemic responses. CB provoked stronger inflammatory activation, while BiB‐PFA caused greater myocardial biomarker release, suggesting energy‐ and device‐specific effects.

8 September 2025 in Heart Rhythm O2
Verified
Journal Article
Open access
JWJan-Per Wenzel
Jan-Per Wenzel
SHSascha Hatahet
Sascha Hatahet
RARaed Abdessadok
Raed Abdessadok
CECharlotte Eitel
Charlotte Eitel
JNJulius Nikorowitsch
Julius Nikorowitsch
RTRoland Richard Tilz
Roland Richard Tilz
Pulsed field ablation (PFA) is a nonthermal technique for pulmonary vein isolation (PVI) in atrial fibrillation, offering lesion selectivity with minimal collateral damage. Despite its nonthermal nature, systemic inflammatory and myocardial responses may occur. Catheter design could modulate these effects. The purpose of this study was to compare inflammatory and myocardial biomarker responses after PFA using balloon-in-basket vs pentaspline catheter systems. This prospective, nonrandomized, single-center study involved venous blood sampling before and the morning after PFA-based PVI using either catheter type. Biomarkers analyzed included leukocytes, C-reactive protein (CRP), platelets, troponin T, creatine kinase (CK), CK-MB, and myoglobin. Eighty patients were included (balloon-in-basket: n = 40; pentaspline: n = 40). Baseline characteristics were comparable. All patients achieved acute and first-pass PVI. The balloon-in-basket group required fewer PFA applications (16 vs 32; P < .001). Leukocyte and CRP rose in both groups, more so with the pentaspline catheter (Δ leukocytes: 0.6 × 109/L vs 1.9 × 109/L, P = .026; Δ CRP: 3.4 mg/L vs 5.1 mg/L, P = .074). Platelet count decreased more in the balloon-in-basket group (Δ platelets −11 × 109/L vs −1 × 109/L; P = .005), while CK increased more in this group (Δ CK 219.5 U/L vs 97.0 U/L; P < .001). Troponin T, CK-MB, and myoglobin changes were similar. Balloon-in-basket and pentaspline PFA catheters induce distinct inflammatory and myocardial biomarker profiles after PVI. The observed differences in leukocyte, CRP, and platelet responses highlight design-specific biological effects. These findings may support informed catheter selection and help guide postprocedural monitoring strategies.

7 March 2026 in Heart Rhythm O2
Verified
Journal Article
Open access
RTRoland Richard Tilz
Roland Richard Tilz
SHSascha Hatahet
Sascha Hatahet
CECharlotte Eitel
Charlotte Eitel
SPSorin Popescu
Sorin Popescu
BSBehnam Subin
Behnam Subin
JWJan-Per Wenzel
Jan-Per Wenzel
Single-shot pulsed field ablation (PFA) is increasingly used for pulmonary vein isolation (PVI) in atrial fibrillation (AF). Although balloon-in-basket (BiB)-PFA system integrates ablation and mapping into a single catheter, standardized procedural workflows remain limited. This study aimed to describe a standardized, step-by-step workflow for AF ablation using the BiB-PFA system and evaluate procedural performance, acute safety, and the learning curve in clinical practice. This prospective, single-center study included 40 consecutive patients undergoing index PVI using the BiB-PFA system at a tertiary high-volume electrophysiology center. Procedures followed standardized protocol including balloon preparation, ultrasound-guided access, fluoroscopy-guided transseptal puncture, selective pulmonary vein (PV) angiography, and a structured 2-step ablation approach for each vein. Posterior wall ablation (PWA) was performed in selected patients. Procedural metrics and acute complications were analyzed descriptively. Patients were 64.5 years old (56.5, 73.3); 41% were female, and 57.5% had nonparoxysmal AF. The median procedural duration was 41.5 minutes (35.0, 59.0), left atrial dwell time 27.5 minutes (25.0, 36.0), and BiB dwell time 23.0 minutes (20.0, 25.8). A median of 4 applications per PV was used. Reduced-energy delivery was required in 30% of right inferior and 25% of right superior PV. PWA was performed in 35% of patients using a median of 5 applications. No major intraprocedural complication occurred. The mean procedural duration decreased from 50.0 minutes (38.0, 60.5) in the first 10 cases to 34.5 minutes (31.5, 52.0) in the last 10 cases (P = .059). A standardized BiB-PFA workflow enables efficient, safe, and reproducible PVI with optional PWA and can be rapidly implemented during early operator experience.

14 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Christian-H HeegerChristian-H Heeger
Christian-H Heeger
SRSamuel Reincke
Samuel Reincke
SPSorin Stefan Popescu
Sorin Stefan Popescu
SHSascha Hatahet
Sascha Hatahet
BSBehnam Subin
Behnam Subin
RTRoland Richard Tilz
Roland Richard Tilz
Background: Atrial fibrillation (AF) remains the most common cardiac arrhythmia, with pulmonary vein isolation (PVI) established as the cornerstone of interventional treatment. However, in patients with persistent AF (PersAF), the success rates of PVI alone tend to be limited. A promising additional target is the left atrial appendage (LAA). In recent years, cryoballoon (CB) technology has become a tool for achieving durable PVI. Its application for LAAI has been investigated as a potentially advantageous alternative to radiofrequency ablation, and a positive effect on long-term outcome has been reported. However, the available data is limited. This study sought to investigate the clinical impact of CB-based LAAI in addition to PVI. Methods: This is a prospective, interventional, single-centre study. Consecutive patients with symptomatic PersAF were prospectively enrolled. In total 23 patients with PersAF underwent PVI plus LAAI using the CB system. Percutaneous LAA closure was performed within 2–3 months in all patients by implanting an endocardial LAA-closure device. Prior to LAA closure, LAAI durability was systematically assessed by invasive remapping studies. Results: A total of 100% of PVs were successfully isolated using the CB only (n = 91/91). Concerning LAAIs, a total of 21/23 (91%) remained isolated at the end of the procedure. After the ablation procedure including LAAI, all patients were scheduled for TEE assessment and LAA closure. TEE was performed after a mean of 54 ± 19 days. In 6/23 (26%) patients, LAA thrombus formation was detected after LAAI. A total of 23/23 patients (100%) received LAAC after a mean of 72 ± 45 days. Durability of LAAI was assessed utilizing a spiral mapping catheter in 23/23 patients (100%). In a total of 17/23 (74%) patients, durable LAA isolation was detected. Durable PVI of all PVs was detected in 16/23 (70%) patients. During a mean follow-up of 13 ± 3.4 months, stable sinus rhythm was maintained in 15 (65%) patients. The LAA showed reconnection in 3/23 (13%) patients, with arrhythmia recurrence. During follow-up, one stroke (318 days after LAAC) and one device thrombus (56 days after LAAC) occurred. Conclusions: While CB-based LAAI may offer benefits in managing persistent AF, it presents a significant risk of thrombus formation in the LAA, even with appropriate OAC. Early closure of the LAA following LAAI appears promising in mitigating these risks, but further evidence is needed to establish clear best practices.

20 June 2026 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Open access
RTRoland Richard Tilz
Roland Richard Tilz
JWJan-Per Wenzel
Jan-Per Wenzel
CECharlotte Eitel
Charlotte Eitel
SPSorin Popescu
Sorin Popescu
MKMirco Küchler
Mirco Küchler
SHSascha Hatahet
Sascha Hatahet
Introduction: Balloon-in-basket pulsed field ablation (BiB-PFA) enables atrial fibrillation (AF) ablation under conscious sedation (CS). While augmented reality (AR) has been proposed to improve patient comfort during invasive procedures, its benefit in an already well-tolerated awake ablation setting remains uncertain. Objective: To evaluate the impact of adjunctive AR glasses on sedation requirements and patient comfort during BiB-PFA performed under CS. Methods: In this prospective, single-center study, 50 patients undergoing AF ablation with BiB-PFA were treated under a standardized CS protocol. Patients were allocated to either ablation without AR ( n = 25) or ablation with adjunctive AR glasses ( n = 25). Sedation requirements and patient-reported outcomes were assessed during ablation, as well as at 1-hour and 1-day post-procedure. Results: Baseline characteristics were comparable. All procedures were completed without conversion to deep sedation. Fentanyl requirements were lower in AR-group (1.1 vs. 1.4 µg/kg; p = 0.015), while other sedatives were similar. Intraprocedural pain was moderate and comparable. AR enhanced perceived calming effect (10.0 vs. 8.5; p = 0.015). Satisfaction was high in both groups. Recommendation scores were high overall, with higher values without AR (90(90,100) vs. 90 (70,90); p = 0.023). Retrospective anxiety at day 1 remained low but was higher with AR (2.0(0.0,5.0) vs. 0.0 (0.0,0.0); p = 0.002). Pain decreased over time in both ( p < 0.001). Conclusion: CS for BiB-PFA is feasible and well tolerated. Intraprocedural pain was low, while satisfaction and recommendation were high in both groups, with slightly higher values without AR support. AR use was associated with modest reduced opioid requirements, suggesting a potential role in selected patients. Slightly higher retrospectively reported anxiety at 1 day in AR-group, while overall low, warrants further investigation.